can you take semaglutide if you have kidney disease Chronic Add-On, Not Replacement: Semaglutide's Role

This process is completed through our secure HIPAA Compliant Kareo platform

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications

Increased Dosing Complexity More injections increase the possibility of: Dosing confusion Missed doses Improper measurements Medication errors Off-Label Use Most FDA-approved GLP-1 medications are designed for once-weekly administration

Focus on Nutrient Density : Every bite should deliver maximum nutritional value

During your consultation, we'll thoroughly discuss any potential side effects and risks associated with these medications to ensure you make an informed decision